{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:14:24Z","timestamp":1791094464752,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.expneurol.2013.03.026","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T09:34:19Z","timestamp":1365240859000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood\u2013brain-barrier damage, inflammation and thrombosis"],"prefix":"10.1016","volume":"247","author":[{"given":"Peter","family":"Kraft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"G\u00f6b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Heydenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.03.026_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pneurobio.2012.11.004","article-title":"Ischemic stroke and traumatic brain injury: the role of the kallikrein\u2013kinin system","volume":"101\u2013102","author":"Albert-Wei\u00dfenberger","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0361-9230(93)90014-3","article-title":"Sequential alteration of [3H]rolipram binding in gerbil brain after transient cerebral ischemia","volume":"31","author":"Araki","year":"1993","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0020","doi-asserted-by":"crossref","first-page":"H2555","DOI":"10.1152\/ajpheart.00588.2004","article-title":"Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion","volume":"287","author":"Arumugam","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2007.08.011","article-title":"Modulation of the cAMP signaling pathway after traumatic brain injury","volume":"208","author":"Atkins","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0030","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/jnr.23069","article-title":"Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury","volume":"90","author":"Atkins","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.10.019","article-title":"Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice","volume":"532","author":"Atkins","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/STROKEAHA.108.526673","article-title":"Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema","volume":"40","author":"Austinat","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1054\/jocn.2001.1031","article-title":"Ischaemic brain oedema","volume":"9","author":"Ayata","year":"2002","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0050","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/STROKEAHA.107.490193","article-title":"Antiedema therapy in ischemic stroke","volume":"38","author":"Bardutzky","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/jcbfm.1994.41","article-title":"Endothelin levels increase in rat focal and global ischemia","volume":"14","author":"Barone","year":"1994","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0060","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuroscience.2009.07.039","article-title":"Effects of rolipram on adult rat oligodendrocytes and functional recovery after contusive cervical spinal cord injury","volume":"163","author":"Beaumont","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0070","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1177\/1352458509345903","article-title":"Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood\u2013brain barrier disruption in multiple sclerosis","volume":"15","author":"Bielekova","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0075","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1097\/00001756-199712010-00033","article-title":"Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats","volume":"8","author":"Block","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0080","first-page":"523","article-title":"Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia","volume":"38","author":"Connolly","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2012.12.056","article-title":"Rolipram promotes functional recovery after contusive thoracic spinal cord injury in rats","volume":"243","author":"Costa","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0223-5234(00)00179-3","article-title":"Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies","volume":"35","author":"Dal Piaz","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1183\/09031936.00071307","article-title":"Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury","volume":"31","author":"de Visser","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.WCB.0000078322.96027.78","article-title":"Cerebral microvessel responses to focal ischemia","volume":"23","author":"del Zoppo","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543784.11.1.1","article-title":"Update on the therapeutic potential of PDE4 inhibitors","volume":"11","author":"Dyke","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-012-1076-3","article-title":"The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury","volume":"125","author":"Enzmann","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-5728(99)00063-6","article-title":"Treatment with BBB022A or rolipram stabilizes the blood\u2013brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors","volume":"97","author":"Folcik","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0120","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1073\/pnas.92.8.3601","article-title":"Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor","volume":"92","author":"Genain","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0125","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/glia.22401","article-title":"Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury","volume":"60","author":"Ghosh","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1245","article-title":"The gene encoding phosphodiesterase 4D confers risk of ischemic stroke","volume":"35","author":"Gretarsdottir","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0135","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.109.924761","article-title":"Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding","volume":"121","author":"Hagedorn","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0140","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/STROKEAHA.112.660340","article-title":"C1-inhibitor protects from brain ischemia\u2013reperfusion injury by combined antiinflammatory and antithrombotic mechanisms","volume":"43","author":"Heydenreich","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0145","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2174\/092986706778773040","article-title":"Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD","volume":"13","author":"Huang","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0150","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(96)00051-3","article-title":"Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats","volume":"68","author":"Jung","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10790268.2009.11760769","article-title":"Systemic administration of rolipram increases medullary and spinal cAMP and activates a latent respiratory motor pathway after high cervical spinal cord injury","volume":"32","author":"Kajana","year":"2009","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2006.09.026","article-title":"Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity","volume":"144","author":"Kanes","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(93)90153-7","article-title":"Alterations in [3H]MK-801, [3H]muscimol, [3H]cyclic AMP, and [3H]rolipram binding in the gerbil hippocampus following repeated ischemic insults","volume":"52","author":"Kato","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0190","series-title":"Inflammation Research Perspectives","first-page":"81","article-title":"Inflammation and the role of immune mediators in the pathophysiology of ischemic stroke","author":"Kleinschnitz","year":"2008"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0185","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","article-title":"Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding","volume":"115","author":"Kleinschnitz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000479","article-title":"Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration","volume":"8","author":"Kleinschnitz","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0200","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/STROKEAHA.110.592238","article-title":"Glucocorticoid insensitivity at the hypoxic blood\u2013brain barrier can be reversed by inhibition of the proteasome","volume":"42","author":"Kleinschnitz","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0205","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2012-04-426734","article-title":"Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature","volume":"121","author":"Kleinschnitz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0210","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/jcbfm.2012.108","article-title":"Next-generation antithrombotics in ischemic stroke: preclinical perspective on \u2018bleeding-free antithrombosis\u2019","volume":"32","author":"Kraft","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0215","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/00498258809041693","article-title":"Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences","volume":"18","author":"Krause","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1254\/jphs.FPJ04009X","article-title":"Phosphodiesterase type IV inhibitors prevent ischemia\u2013reperfusion-induced gastric injury in rats","volume":"95","author":"Kyoi","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0225","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1182\/blood-2012-06-440057","article-title":"Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood\u2013brain barrier damage, and inflammation","volume":"120","author":"Langhauser","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11011-011-9235-0","article-title":"Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats","volume":"26","author":"Li","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2350-11-93","article-title":"Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis","volume":"11","author":"Liao","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0240","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/WCO.0b013e328352ede6","article-title":"Immune mechanisms of stroke","volume":"25","author":"Magnus","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0245","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/hs0901.94259","article-title":"Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats","volume":"32","author":"Matsuo","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mvr.2009.08.008","article-title":"Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice","volume":"78","author":"Mendes","year":"2009","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1124\/jpet.106.106096","article-title":"Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis","volume":"319","author":"Moore","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0260","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1073\/pnas.92.12.5341","article-title":"Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein","volume":"92","author":"Moran","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0265","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1113\/jphysiol.2011.212886","article-title":"Ischaemic stroke: a thrombo-inflammatory disease?","volume":"589","author":"Nieswandt","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0270","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1073\/pnas.0402595101","article-title":"The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery","volume":"101","author":"Nikulina","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0275","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1046\/j.1523-1755.2001.00726.x","article-title":"Enhanced protection from renal ischemia\u2013reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition","volume":"59","author":"Okusa","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0280","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/13543770903313753","article-title":"PDE4 inhibitors: a review of current developments (2005\u20132009)","volume":"19","author":"Pag\u00e8s","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0285","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm1056","article-title":"cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury","volume":"10","author":"Pearse","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0290","first-page":"110","article-title":"Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody","volume":"33","author":"Rodr\u00edguez-Palmero","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0295","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1083\/jcb.200701040","article-title":"p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4\/cAMP\/PKA pathway","volume":"177","author":"Sachs","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm0395-244","article-title":"The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis","volume":"1","author":"Sommer","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0305","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","article-title":"Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a \u2018low-affinity\u2019 phosphodiesterase 4 conformer","volume":"118","author":"Souness","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0310","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bjp.0704336","article-title":"Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury","volume":"134","author":"Souza","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1750-3639.2004.tb00497.x","article-title":"Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages","volume":"14","author":"Stoll","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000045539","article-title":"Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis","volume":"84","author":"Tam","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0325","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/01.WCB.0000126974.07553.86","article-title":"Transient focal ischemia affects the cAMP second messenger system and coupled dopamine D1 and 5-HT1A receptors in the living monkey brain: a positron emission tomography study using microdialysis","volume":"24","author":"Tsukada","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0330","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.20953","article-title":"Delayed Nogo receptor therapy improves recovery from spinal cord contusion","volume":"60","author":"Wang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0335","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","article-title":"The blood\u2013brain barrier in brain homeostasis and neurological diseases","volume":"1788","author":"Weiss","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2013.03.026_bb0340","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neulet.2008.03.087","article-title":"Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury","volume":"438","author":"Whitaker","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1159\/000335785","article-title":"Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells","volume":"28","author":"Yang","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0350","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.thromres.2011.12.008","article-title":"PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells","volume":"129","author":"Yang","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/135245859900500210","article-title":"Effects of phosphodiesterase inhibitors on cytokine production by microglia","volume":"5","author":"Yoshikawa","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.expneurol.2013.03.026_bb0360","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1527-3458.2001.tb00206.x","article-title":"The antidepressant and antiinflammatory effects of rolipram in the central nervous system","volume":"7","author":"Zhu","year":"2001","journal-title":"CNS Drug Rev."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T23:58:18Z","timestamp":1539734298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488613001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":72,"alternative-id":["S0014488613001192"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.026","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood\u2013brain-barrier damage, inflammation and thrombosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}